Journal of the Bahrain Medical Society
Year 2023, Volume 35, Issue 2, Pages 43-47
https://doi.org/10.26715/jbms.35_2_6Salem Alrowaijeh1*, Rana Taqi2, Ebrahim Almasry1, Jalal AlKhan1
1Anesthesia, Bahrain Defense Force Military Hospital, Bahrain
2Intern, Bahrain Defense Force Military Hospital, Bahrain
*Corresponding author:
Dr. Salem Alrowaijeh, Anesthesia, Bahrain Defense Force Military Hospital, Bahrain; Email: salrowaijeh@hotmail.com
Received date: November 05, 2022; Accepted date: February 20, 2023; Published date: June 30, 2023
For tables and figures, please refer to PDF.
Abstract
Regardless of ethnicity or geographical distribution, Wiskott-Aldrich syndrome affects 1 in every 100,000 live male births. It has been established that Wiskott-Aldrich syndrome may potentially be a source of autoimmune illnesses and reticuloendothelial malignancies, even though most patients present with the traditional triad of thrombocytopenia, eczema, and recurrent bacterial infections. This case report introduces a 4-year-old boy born with hematemesis, thrombocytopenia, eczema, recurring infections, and, most surprisingly, normal platelet size. Genetic testing confirmed the diagnosis, primarily based on clinical suspicion. Thus the case study attempts to increase awareness among doctors in Bahrain and globally in considering the diagnosis of Wiskott-Aldrich syndrome in any patient with eczema, recurrent infections and thrombocytopenia regardless of having a normal mean platelet volume .
Keywords: Genetic testing, immunity disorder, primary immunodeficiency disorder, thrombocytopenia, Wiskott-Aldrich syndrome